Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04706598
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2020-12-27
Brief Title:
Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
Sponsor:
Fudan University
Organization:
Fudan University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Immunotherapy |
| Urinary Bladder Neoplasms |
Keywords: